1.0CLP Bloghttps://clpblog.citizen.orgBrian Wolfmanrich600338<blockquote class="wp-embedded-content" data-secret="kIM4Q39VVw"><a href="https://clpblog.citizen.org/number-of-fda-orphan-drug-designations-rising-dramatically/">Number of FDA “orphan drug” designations rising dramatically</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://clpblog.citizen.org/number-of-fda-orphan-drug-designations-rising-dramatically/embed/#?secret=kIM4Q39VVw" width="600" height="338" title="“Number of FDA “orphan drug” designations rising dramatically” — CLP Blog" data-secret="kIM4Q39VVw" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> This short article by Gayatri Rao, the Food and Drug Administration's director of Orphan Products Development, explains that, in recent years, drug companies have been filing many more "orphan drug" applications than they used to. Orphan drugs are drugs aimed at treating people with rare diseases. Drug companies sometimes say that it's too costly for them [...]